Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Analysis of the time and age dependence of the case-fatality-ratio for COVID-19 in seven countries with a high total-to-positive test ratio suggests that the true CFR may be significantly underestimated for the United States in current models

Jessica Rothman, David Eidelberg, Samantha Rothman, Theodore Holford, Douglas L Rothman
doi: https://doi.org/10.1101/2020.05.13.20101022
Jessica Rothman
1Department of Biostatistics. Ph.D. Student. Yale University School of Public Health, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jessica.rothman@yale.edu
David Eidelberg
2Center for Neurosciences, Institute of Molecular Medicine, Northwell Health, Manhasset, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Rothman
3Departments of Mathematics and Computer Science. Tulane University, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theodore Holford
4Departments of Biostatistics, and Statistics and Data Science. Yale University School of Public Health and Yale University Graduate School of Arts and Sciences, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas L Rothman
5Departments of Radiology and Biomedical Engineering. Yale University School of Medicine, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Knowing the true infected and symptomatic case fatality ratios (IFR and CFR) for COVID-19 is of high importance for epidemiological model projections. A large correction factor is usually applied for missed cases. For the United State reported CFR of 5.96%, the estimated IFR values are 10–50-fold lower, justified by early reported CFR values of 0.1% to 0.5% in countries with more extensive testing. However, since then these values have risen 5 to 10-fold. We analyzed their age dependent CFR time courses to explain this increase and to determine whether a common factor can explain their CFRs.

Methods Age dependent time to fatality corrected CFR was calculated using two independent methods. A linear model was developed that predicts CFR based on age dependent CFR coefficients and the age distribution of cases. The model was tested by a linear regression of each country’s CFR against case percentage of 70 years and over. The model was further tested by calculating the percent of the population in New York City who have been infected.

Results Corrected CFR values ranged from 0.58% to 5.0%. The large majority of CFR variation was explained by case age distribution above 70 years old. Using the CFR derived from the linear model we predicted between 14.7% and 22% of the adult population in NYC had been infected by COVID-19, in agreement with random testing studies (15.3% – 21%).

Conclusions The large rise in the reported CFR is due to the delay time between infection/diagnosis and fatality with COVID-19. The linear model based on their age specific CFR values provides an alternative method for calculating the true CFR in other regions. Most of the variation in CFR between countries was dependent on case age distribution, which must be considered in measures for mitigating the extensive impacts of the pandemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors did not receive any external funding for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All relevant ethical guidelines have been followed.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data is available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Analysis of the time and age dependence of the case-fatality-ratio for COVID-19 in seven countries with a high total-to-positive test ratio suggests that the true CFR may be significantly underestimated for the United States in current models
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Analysis of the time and age dependence of the case-fatality-ratio for COVID-19 in seven countries with a high total-to-positive test ratio suggests that the true CFR may be significantly underestimated for the United States in current models
Jessica Rothman, David Eidelberg, Samantha Rothman, Theodore Holford, Douglas L Rothman
medRxiv 2020.05.13.20101022; doi: https://doi.org/10.1101/2020.05.13.20101022
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Analysis of the time and age dependence of the case-fatality-ratio for COVID-19 in seven countries with a high total-to-positive test ratio suggests that the true CFR may be significantly underestimated for the United States in current models
Jessica Rothman, David Eidelberg, Samantha Rothman, Theodore Holford, Douglas L Rothman
medRxiv 2020.05.13.20101022; doi: https://doi.org/10.1101/2020.05.13.20101022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)